SAM, Linklaters, JSA Act On Biocon’s $460 Million QIP Biopharamaceuticals January 19, 2026 Capital Markets
SAM, JSA Advised On Tonbo Imaging’s Proposed IPO Manufacturing January 5, 2026 Capital Markets – Equity
SAM, JSA Advised On CORONA Remedies’ ₹655 Cr IPO Pharmaceuticals December 25, 2025 Capital Markets – Equity
JSA Advised Syrma SGS Technology On Its ₹1000 Cr QIP Electronics Manufacturing August 20, 2025 Capital Markets – Equity
JSA Advised Biocon Limited In Raising ₹4500 Cr Through A QIP Biopharamaceuticals June 27, 2025 Capital Markets – Equity
